ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 69 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $160,000 | -1.2% | 16,450 | -11.7% | 0.02% | -4.8% |
| Q1 2018 | $162,000 | -54.5% | 18,620 | -34.6% | 0.02% | -46.2% |
| Q4 2017 | $356,000 | +49.6% | 28,470 | 0.0% | 0.04% | +44.4% |
| Q3 2017 | $238,000 | -75.4% | 28,470 | -50.1% | 0.03% | -75.5% |
| Q2 2017 | $968,000 | +5.6% | 57,070 | +25.1% | 0.11% | +2.8% |
| Q1 2017 | $917,000 | +151.2% | 45,620 | +95.0% | 0.11% | +143.2% |
| Q4 2016 | $365,000 | – | 23,395 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |